imito AG Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • imito AG's estimated annual revenue is currently $1.7M per year.(i)
  • imito AG's estimated revenue per employee is $87,000

Employee Data

  • imito AG has 19 Employees.(i)
  • imito AG grew their employee count by -10% last year.

imito AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$57.6M31824%N/AN/A
#2
$44.6M28623%$25.4MN/A
#3
$5.1M44-6%N/AN/A
#4
$35.1M225-3%$46.9MN/A
#5
$14.5M1005%N/AN/A
#6
$1.3M15-6%N/AN/A
#7
$1.5M170%N/AN/A
#8
$2.9M29-12%N/AN/A
#9
$125.2M6916%N/AN/A
#10
$95.9M529-1%N/AN/A
Add Company

What Is imito AG?

imito is a platform that offers services to integrate mobile photography into existing workflows. imito's solution for mobile clinical imaging enables health professionals to easily create visual records of patient conditions using mobile devices. In order to facilitate the exchange of images, videos and other types of information among hospital teams, we offer a collaboration feature. Physicians can capture, archive and share pictures, as well measure and categorize wounds in an efficient, secure and privacy compliant way. imito also allows active patient engagement in their own care. Privacy policy: https://imito.io/privacy-policy-social-media Impressum/Site-Notice: https://imito.io/site-notice

keywords:N/A

N/A

Total Funding

19

Number of Employees

$1.7M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

imito AG News

2022-03-22 - 2021 Mobile Medical Imaging, Wound Care Solutions, and Medical Exoskeletons Industry Report - Featuring Clinomic, Czech Academy of Sciences and Emovo Care Among Others - ResearchAndMarkets.com

Imito Ag. Kth Royal Institute of Technology. Medkitdoc. Siemens Healthineers Ag. Key Topics Covered: Innovations in Medical Devices and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M19N/AN/A
#2
$1.6M19-17%N/A
#3
$1.9M190%N/A
#4
$1.8M205%N/A
#5
$3.1M20N/AN/A